Literature DB >> 28465732

Gray Matter Changes in Demyelinating Disease: Correlations with Clinical Scores.

Mihaela Onu1, Adina Aroceanu2, Victor Ferastraoaru3, Ovidiu Bajenaru4.   

Abstract

BACKGROUND AND
PURPOSE: Recent MR studies have shown that, in multiple sclerosis, selective regional, but not global gray matter atrophy occurs in multiple sclerosis. Our aim was to identify specific areas of gray matter volume changes and explore the relationship between atrophy and clinical motor outcomes.
METHODS: Nine patients with relapsing remitting MS and 9 matched healthy controls were recruited. The Multiple Sclerosis Functional Composite was administered. For MR acquisitions, a GE- Genesis- Signa, 1.5T MR system, was used. A voxel-based morphometry (VBM), subcortical structures segmentation (FIRST) and volumetric (SIENAx) FSL tools were used in the study.
RESULTS: Group comparison showed atrophy for several gray matter regions. The most important volume reductions were found for subcortical deep gray matter areas. Correlations with clinical scores were checked and specific gray matter areas showed significant volume reductions associated with motor scores (9-hole peg time and 25-feet walk time) and EDSS (Expanded Disability Status Scale).
CONCLUSION: We performed a voxelwise analysis of gray matter changes in MS and found a more prominent atrophy for the subcortical structures than for cortical gray matter. Using an additional analysis (FIRST and SIENAx segmentation/volumetry) we were able to confirm the VBM results and to quantify the degree of atrophy in specific structures. Specific gray matter regions which volume reductions correlate with 25-feet walk, 9-hole peg times and EDSS suggest that 25-feet walk time is the best predictor of disease progression in terms of gray matter reduction.

Entities:  

Year:  2015        PMID: 28465732      PMCID: PMC5394444     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  22 in total

1.  Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.

Authors:  Arnaud Charil; Alain Dagher; Jason P Lerch; Alex P Zijdenbos; Keith J Worsley; Alan C Evans
Journal:  Neuroimage       Date:  2006-11-16       Impact factor: 6.556

2.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.

Authors:  Sonia Batista; Robert Zivadinov; Marietta Hoogs; Niels Bergsland; Mari Heininen-Brown; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2011-07-01       Impact factor: 4.849

3.  Thalamic neurodegeneration in multiple sclerosis.

Authors:  Alberto Cifelli; Marzena Arridge; Peter Jezzard; Margaret M Esiri; Jacqueline Palace; Paul M Matthews
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

4.  Diffusion abnormality maps in demyelinating disease: correlations with clinical scores.

Authors:  Mihaela Onu; Adina Roceanu; Uta Sboto-Frankenstein; Robert Bendic; Eugen Tarta; Florentin Preoteasa; Ovidiu Bajenaru
Journal:  Eur J Radiol       Date:  2012-01-17       Impact factor: 3.528

5.  Thalamic atrophy and cognition in multiple sclerosis.

Authors:  M K Houtchens; R H B Benedict; R Killiany; J Sharma; Z Jaisani; B Singh; B Weinstock-Guttman; C R G Guttmann; R Bakshi
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

6.  Gray matter atrophy in multiple sclerosis: a longitudinal study.

Authors:  Elizabeth Fisher; Jar-Chi Lee; Kunio Nakamura; Richard A Rudick
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

7.  Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.

Authors:  E M Mowry; A Beheshtian; E Waubant; D S Goodin; B A Cree; P Qualley; R Lincoln; M F George; R Gomez; S L Hauser; D T Okuda; D Pelletier
Journal:  Neurology       Date:  2009-05-19       Impact factor: 9.910

Review 8.  Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.

Authors:  Alireza Minagar; Eduardo Gonzalez Toledo; J Steven Alexander; Roger E Kelley
Journal:  J Neuroimaging       Date:  2004-07       Impact factor: 2.486

9.  Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.

Authors:  Deepa Preeti Ramasamy; Ralph H B Benedict; Jennifer L Cox; David Fritz; Nadir Abdelrahman; Sara Hussein; Alireza Minagar; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol Sci       Date:  2009-02-06       Impact factor: 3.181

10.  Focal thinning of the cerebral cortex in multiple sclerosis.

Authors:  Michael Sailer; Bruce Fischl; David Salat; Claus Tempelmann; Mircea Ariel Schönfeld; Evelina Busa; Nils Bodammer; Hans-Jochen Heinze; Anders Dale
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

View more
  2 in total

1.  On the Effects of Transcranial Direct Current Stimulation on Cerebral Glucose Uptake During Walking: A Report of Three Patients With Multiple Sclerosis.

Authors:  Thorsten Rudroff; Alexandra C Fietsam; Justin R Deters; Craig D Workman; Laura L Boles Ponto
Journal:  Front Hum Neurosci       Date:  2022-01-25       Impact factor: 3.169

Review 2.  Brain imaging of locomotion in neurological conditions.

Authors:  Gilles Allali; Helena M Blumen; Hervé Devanne; Elvira Pirondini; Arnaud Delval; Dimitri Van De Ville
Journal:  Neurophysiol Clin       Date:  2018-10-25       Impact factor: 3.734

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.